Skip to main
CME
CME logo

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 35 analyst ratings
Hold
Strong Buy 17%
Buy 23%
Hold 43%
Sell 9%
Strong Sell 9%

Bulls say

CME Group's stock outlook remains positive, primarily driven by robust growth in average daily volume (ADV) across key product segments, including a record performance in Henry Hub Natural Gas and significant increases in equity index and crypto futures. The firm's solid financial health is exemplified by a 9% year-over-year increase in its quarterly dividend, marking 14 consecutive years of dividend growth, alongside strong free cash flow generation that enables opportunistic share repurchases. Furthermore, the diversification into cash foreign exchange and collateral optimization, combined with the exclusive trading rights for S&P futures contracts, positions CME Group advantageously within the derivatives market.

Bears say

CME Group has recently faced challenges in its agricultural commodity sector, specifically with a noticeable decline in trading activity in soybean markets, attributed to favorable weather conditions in South America leading to potential record production. Additionally, a downside scenario projects approximately a 10% decrease in expected FY26 EPS, which could result in a significant negative impact on the stock's valuation, especially if open interest experiences a continuous decline, raising concerns about deteriorating market sentiment. Although market data and information services revenue slightly exceeded consensus expectations, overall trading volume remains soft, indicating potential ongoing pressures that could negatively affect the future performance of CME Group's stock.

CME Group (CME) has been analyzed by 35 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 23% recommend Buy, 43% suggest Holding, 9% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Hold based on their latest research and market trends.

According to 35 analysts, CME Group (CME) has a Hold consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $213.03, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $213.03, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.